cryptotanshinone has been researched along with Granulocytic Leukemia, Chronic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, R; Fang, Y; Ge, Y; Huang, Y; Wang, Q; Yan, M | 1 |
| Chen, Z; Dong, B; Li, B; Liang, Z; Qu, L; Yang, J; Zheng, L; Zhou, H | 1 |
| Chen, Z; Cheng, R; Dai, Q; Ge, Y; Xu, X; Yang, B | 1 |
| Chen, Z; Cheng, RB; Ge, YQ; Huang, Z; Yang, B | 1 |
| Chen, CY; Jeong, SJ; Jung, JH; Kim, JH; Kim, M; Kim, SH; Ko, SG; Kwon, TR; Lee, HJ; Lee, MH; Yun, SM | 1 |
| Chu, T; Fu, HM; Jia, YQ; Li, H; Mao, SJ; Meng, WT; Shi, HY; Song, XR; Zhang, Q | 1 |
| Chen, Z; Cheng, R; Dai, Q; Ge, Y; Jia, J; Liu, P; Ma, X; Peng, L; Shen, J; Wang, H; Xu, X; Zhou, Y | 1 |
7 other study(ies) available for cryptotanshinone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia.
Topics: Animals; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Eukaryotic Initiation Factor-4E; Female; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Nude; Phenanthrenes; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; Interleukin-6; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Phenanthrenes; Phosphorylation; Proto-Oncogene Proteins c-myc; STAT3 Transcription Factor; STAT5 Transcription Factor | 2018 |
Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells.
Topics: Apoptosis; Blotting, Western; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Drugs, Chinese Herbal; Eukaryotic Initiation Factor-4E; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenanthrenes; Phosphorylation; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2015 |
[Effect of cryptotanshinone on imatinib sensitivity and P-glycoprotein expression of chronic myeloid leukemia cells].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Caspase 9; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenanthrenes | 2015 |
Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Drug Synergism; Enzyme Activation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Kinase Kinases; NF-kappa B; Phenanthrenes; Proto-Oncogene Proteins; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha | 2011 |
Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microscopy, Fluorescence; Phenanthrenes; Structure-Activity Relationship; Time Factors | 2012 |
Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.
Topics: Apoptosis; Cell Cycle Checkpoints; Cyclin D1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Peptide Chain Initiation, Translational; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2 | 2012 |